{{Rsnum
|rsid=6754521
|Chromosome=2
|position=201994894
|Orientation=plus
|GMAF=0.1882
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.5 | 45.5 | 40.0
| HCB | 2.3 | 16.3 | 81.4
| JPT | 0.0 | 7.7 | 92.3
| YRI | 1.9 | 7.4 | 90.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.3 | 16.3 | 81.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=5E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | HumanOmni1Quad}}